Non-alcoholic fatty liver disease (NAFLD) is a hepatic metabolic syndrome resulting from lipid metabolic imbalance.

A drug and alcohol charity in Leeds has said it has "micro-eliminated" hepatitis C - meaning it has identified, treated and ...

Non-alcoholic fatty liver disease (NAFLD) is a hepatic metabolic syndrome resulting from lipid metabolic imbalance.

What's been exciting over the last 5-10 years has been the growing body of evidence with interferon alpha therapy for these diseases that really looks like it has an impact on preventing the ...

Ainos (AIMD) announced progress in advancing its oral interferon drug platform, VELDONA in the rare disease space. The Taiwan Food and Drug ...

In Mycobacterium abscessus complex pulmonary disease, elevated levels of IFN-γ and IL-17F may signal higher risk for disease ...

Ainos (AIMD) announced progress in advancing its oral interferon drug platform, Veldona in the rare disease space. The Taiwan FDA has approved ...

A significant discovery has identified a missing "gatekeeper" protein as the root cause of dry mouth in Sjögren's syndrome — a finding that could change the way the disease is treated.